Tibidabo Scientific Industries Appoints Paul McEvoy as Chief Commercial Officer

8th Jan, 2024

DUBLIN, January 08, 2024 — Tibidabo Scientific Industries Ltd (“Tibidabo Scientific”) is delighted to announce the appointment of Paul McEvoy as Chief Commercial Officer. In this pivotal role, Paul will lead the way in the formation and implementation of a unified sales and marketing strategy across all Tibidabo Scientific companies.

With his extensive experience and a deep understanding of the imaging, medical device, irradiation, and research sectors, Paul’s strategic approach aligns seamlessly with Tibidabo Scientific’s vision for innovation and global commitment to state-of-the-art solutions.

A distinguished graduate of University College Dublin, Paul brings over ten years of leadership in sales and marketing, demonstrating success with effective go-to-market strategies in the United States and internationally. Notably, in the Women’s Health space, he has been instrumental in driving sales growth, forging strategic partnerships, and enhancing market presence.

“We are thrilled to welcome Paul to Tibidabo Scientific,” said Viktoriya Baytser, President of Tibidabo Scientific. “His unique blend of experience and expertise in sales and marketing makes him an excellent match for our executive team. We are confident that his strategic vision, dedication and leadership will be a driving force in the commercial success of Tibidabo Scientific.”

Expressing his enthusiasm about the new role, Paul added, “I am honoured and excited to join the Tibidabo family, a company renowned for its commitment to innovation and excellence across diverse markets. I look forward to contributing to the organization’s continued growth and success by leveraging my experience to develop impactful commercial strategies.”

This strategic appointment underscores Tibidabo Scientific’s commitment to strengthening its core leadership team and forging market leading positions in the scientific research, aerospace, and industrial markets.